LMATLeMaitre Vascular, Inc.

$80.67-12% 1Y

The financials

LeMaitre Vascular, Inc. by the numbers

LeMaitre Vascular, Inc. (LMAT) reported revenue of $70M in Q2 2026 (quarter ended Jun 30, 2026), up 9.6% from the same quarter a year earlier. That came with a gross margin of 72% and net income of $17M (24% of revenue). For the full year FY2025, revenue was $250M (+14% year on year) and net income $58M. Its largest region in Q2 2026 was United States at $38M, 54% of the disclosed total, well ahead of Other Countries at 26%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.

LeMaitre Vascular, Inc. income statement, Q2 2026 against the same quarter a year earlier
Income statementQ2 2026Q2 2025Change
Revenue$70M$64M+9.6%
Gross profit$51M$45M+13%
Operating income$20M$16M+26%
Net income$17M$14M+24%
Diluted EPS$0.74$0.60+23%
Revenue by region, Q2 2026, as reported to the SEC
GeographicRevenueShare
United States$38M54%
Other Countries$19M26%
Germany$5.3M7.6%
Canada$4.6M6.5%
United Kingdom$3.7M5.3%

Business segments

Revenue split by geographic segment, from SEC XBRL filings.

Latest period: Jun 2026Total $70.4M (+5.8%)
Germany grew +20% year on yearUnited States +4.3% year on year
  • United States$38.3Mquarter on quarter +2.9%year on year +4.3%
  • Other Countries$18.5Mquarter on quarter +11%year on year +17%
  • Germany$5.3Mquarter on quarter -3.6%year on year +20%
  • Canada$4.6Mquarter on quarter +12%year on year +15%
  • United Kingdom$3.7Mquarter on quarter +19%year on year +13%
Segment sum = 100% of reported consolidated revenue · Latest source: 10-Q filed Aug 5, 2026, SEC EDGAR